Peregrine Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Peregrine Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-544,364	Closed	-$25.2M	–	323
2019 Q2	$25.2M	Sell	544,364 -417,284	-43%	-$11.7M	0.62%	44
2019 Q1	$23.4M	Sell	961,648 -150,000	-13%	-$3.12M	0.59%	50
2018 Q4	$15.8M	Sell	1,111,648 -6,756	-0.6%	-$102K	0.45%	91
2018 Q3	$17M	Buy	+1,118,404	New	+$17.1M	0.4%	116

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Peregrine Capital Management's ARRY Position: Q3 2019 in Review

Peregrine Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 544,364 shares — an estimated $25.2M sold.

Peregrine Capital Management first reported a position in ARRY in Q3 2018 and held it in 4 quarters. The position peaked at $25.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Peregrine Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Peregrine Capital Management sold 544,364 Array Biopharma Inc shares in Q3 2019, an estimated $25.2M.
Peregrine Capital Management first reported a position in Array Biopharma Inc in Q3 2018 and held it in 4 quarters.
Peregrine Capital Management's Array Biopharma Inc position peaked at $25.2M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Peregrine Capital Management's 13F filing for Q3 2019, filed 16 Oct 2019.